Nissan Medical Industries Ltd reported earnings results for the third quarter and nine months ended September 30, 2021. For the third quarter, the company reported sales was ILS 147.51 million compared to ILS 180.42 million a year ago. Net loss was ILS 2.41 million compared to net income of ILS 15.24 million a year ago. Basic loss per share from continuing operations was ILS 0.28 compared to basic earnings per share from continuing operations of ILS 1.68 a year ago. For the nine months, sales was ILS 495.76 million compared to ILS 541.84 million a year ago. Net income was ILS 30.94 million compared to ILS 39.12 million a year ago. Basic earnings per share from continuing operations was ILS 3.39 compared to ILS 4.31 a year ago. Diluted earnings per share from continuing operations was ILS 3.39 compared to ILS 4.31 a year ago.